MedPageToday -- SAN DIEGO -- Use of radiation therapy in early-stage Hodgkin’s disease has declined by more than 30% over the past 20 years, despite consistent evidence of a survival benefit, data from a large retrospective review showed.
MedPageToday -- SAN DIEGO -- Use of radiation therapy in early-stage Hodgkin’s disease has declined by more than 30% over the past 20 years, despite consistent evidence of a survival benefit, data from a large retrospective review showed.